Global Medical Education Market 2022-2026 The analyst has been monitoring the medical education market and it is poised to grow by $ 173. 36 bn during 2022-2026, accelerating at a CAGR of 16.
New York, Sept. 06, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Medical Education Market 2022-2026” – https://www.reportlinker.com/p04706407/?utm_source=GNW
95% during the forecast period. Our report on the medical education market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth in the number of online medical education programs, the advent of visual technologies in medical education, and the rise in organic growth.
The medical education market analysis includes the courses and learning methods segments and geographic landscape.
The medical education market is segmented as below:
• Graduate courses
• Certifications and training
• Post-graduate courses
By Learning Methods
• Blended learning
• Online learning
By Geographical Landscape
• North America
• South America
This study identifies the rise in organic growth as one of the prime reasons driving the medical education market growth during the next few years. Also, the increase in partnerships between medical universities and associations and the rise in the number of medical boot camps will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the medical education market covers the following areas:
• Medical education market sizing
• Medical education market forecast
• Medical education market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical education market vendors that include All India Institute of Medical Sciences, Grand Canyon University, Harvard Medical School, Johns Hopkins University, Mayo Foundation for Medical Education and Research, National University of Singapore, New York University, Stanford Medicine, TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER, The Kaiser Permanente Bernard J. Tyson School of Medicine, The University of Alabama, University of California, University of Cambridge, University of Eastern Finland, University of Liverpool, University of New England, University of Oxford, University of Washington, Western Governors University, and Yale University. Also, the medical education market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report: https://www.reportlinker.com/p04706407/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Nio (NYSE: NIO) recently reported its second-quarter results, and there were a couple of things the company should be proud of. Mainly, the company's revenue and vehicle sales saw significant increases from the year-ago quarter. In the recent past, climbing revenue and rising vehicle sales would have likely sparked positive sentiment among electric vehicle investors.
Bill Gates looks for income, too. This is how he gets it.
"We believe Sotyktu is a breakthrough in the treatment of patients suffering from moderate-to-severe plaque psoriasis," said Bristol Myers' chief medical officer Samit Hirawat.
‘Rich Dad Poor Dad’ sees a window to get rich. He might be right.
Among six high-profile stock splits — Alphabet, Amazon, Tesla, Shopify, DexCom, and Palo Alto Networks — is a clear-cut bargain, as well as a company with serious red flags.
Billionaires buy dividend stocks for the same reasons other people do. Of course, they also prefer that their stocks grow as well as pay dividends. Here are three dividend stocks that billionaires Buffett and Soros both own.
Feeling bearish? Take shelter — and income.
Occidental Petroleum shares jumped higher Monday after billionaire investor Warren Buffett added to both his stake in the oil major and speculation that he may be preparing to buy at least half of its outstanding stock. Buffett boosted his holding in Occidental, which he has been adding to for most of the year, to 26.8%, according to Securities & Exchange Commission filings from late last week, after buying an additional 51.99 million shares. The move came shortly after the Federal Energy Regulatory Commission (FERC) said in late August that Berkshire Hathaway's additional investment in Occidental was "consistent with the public interest", giving Buffett the nod to purchase "up to 50%" of the oil major's common shares.
A bear market isn't enough to chase billionaire hedge fund manager Ken Griffin of Citadel to the sideline.
Though retirees are only required to take a certain portion of their retirement savings out as distributions each year, a study from JPMorgan Chase shows that there is likely good reason to take out more. A withdrawal approach based solely on … Continue reading → The post 84% of Retirees Are Making This RMD Mistake appeared first on SmartAsset Blog.
Oil prices have been all over the map this year. Oil's next step is anyone's guess. Three oil companies that our energy contributors think look like no-brainer investments in the current environment are TotalEnergies (NYSE: TTE), Chevron (NYSE: CVX), and ExxonMobil (NYSE: XOM).
In today's volatile market, there's a lot to be said for seeking out boring businesses at cheap prices.
Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.
Carnival (NYSE: CCL) (NYSE: CUK) experienced its very worst time when the pandemic forced its ships to shore. Concerns about higher interest rates and a weakening economy are weighing on the shares these days. Considering future prospects, should you buy Carnival before it rallies?
There's a bond that pays a 9.62% interest rate and is guaranteed by the U.S. Treasury. Investors should keep some limitations and conditions in mind before investing, but as inflation has topped 8% since March 2022, this could be an … Continue reading → The post Want 9.62% Yield Guaranteed? Seriously, Try This Asset appeared first on SmartAsset Blog.
Developing innovative products is an excellent way for a company to become successful, and that's what Inovio Pharmaceuticals (NASDAQ: INO) is looking to do. Let's look at one reason Inovio could be an exciting contrarian buy, and one reason to stay away. Small-cap biotechs need promising pipeline programs to attract attention.
As different as they seem, both quiet-quitters and FIRERS want the same thing.
The housing market is changing fast. Act accordingly.
In this article, we discuss the 10 best energy stocks to buy now. If you want to skip our industry overview, take a look at the 5 Best Energy Stocks to Buy Now. The Covid-19 pandemic was difficult for the energy sector. Global travel restrictions brought on by the Covid-19 outbreak reduced demand for oil […]
Investors today can take advantage of buying opportunities in the tech sector that were almost unimaginable just a year ago.